N Sivalingam

1.4k total citations · 1 hit paper
44 papers, 1.0k citations indexed

About

N Sivalingam is a scholar working on Molecular Biology, Oncology and Cardiology and Cardiovascular Medicine. According to data from OpenAlex, N Sivalingam has authored 44 papers receiving a total of 1.0k indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Molecular Biology, 8 papers in Oncology and 7 papers in Cardiology and Cardiovascular Medicine. Recurrent topics in N Sivalingam's work include Curcumin's Biomedical Applications (6 papers), Genomics, phytochemicals, and oxidative stress (3 papers) and Biochemical and biochemical processes (3 papers). N Sivalingam is often cited by papers focused on Curcumin's Biomedical Applications (6 papers), Genomics, phytochemicals, and oxidative stress (3 papers) and Biochemical and biochemical processes (3 papers). N Sivalingam collaborates with scholars based in Malaysia, India and United States. N Sivalingam's co-authors include Sruthi Sritharan, Ganesan Ramamoorthi, Molly Jacob, Jayasree Basivireddy, Kunissery A. Balasubramanian, Ayushi Agarwal, Alec N. Woosley, Sneha Natarajan, Philip H. Howe and Yong Jiang and has published in prestigious journals such as SHILAP Revista de lepidopterología, Nature Cell Biology and Life Sciences.

In The Last Decade

N Sivalingam

44 papers receiving 1.0k citations

Hit Papers

A comprehensive review on time-tested anticancer drug dox... 2021 2026 2022 2024 2021 100 200 300

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
N Sivalingam Malaysia 17 334 144 116 108 100 44 1.0k
Zhimin Chen China 19 556 1.7× 266 1.8× 134 1.2× 34 0.3× 75 0.8× 60 1.6k
Naïma Zerrouk France 23 353 1.1× 68 0.5× 142 1.2× 63 0.6× 128 1.3× 29 1.8k
Jamal Hallajzadeh Iran 22 402 1.2× 50 0.3× 81 0.7× 26 0.2× 135 1.4× 63 1.2k
Min Guo China 28 485 1.5× 74 0.5× 96 0.8× 28 0.3× 215 2.1× 69 1.9k
Osama A. A. Ahmed Saudi Arabia 28 551 1.6× 118 0.8× 126 1.1× 47 0.4× 299 3.0× 111 2.1k
Zhengfang Lin China 21 410 1.2× 74 0.5× 54 0.5× 24 0.2× 222 2.2× 36 1.5k
Allan J. Coukell United States 15 172 0.5× 92 0.6× 178 1.5× 43 0.4× 64 0.6× 23 1.1k
Venkatesh Pooladanda India 19 380 1.1× 71 0.5× 100 0.9× 28 0.3× 54 0.5× 32 1.6k

Countries citing papers authored by N Sivalingam

Since Specialization
Citations

This map shows the geographic impact of N Sivalingam's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by N Sivalingam with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites N Sivalingam more than expected).

Fields of papers citing papers by N Sivalingam

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by N Sivalingam. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by N Sivalingam. The network helps show where N Sivalingam may publish in the future.

Co-authorship network of co-authors of N Sivalingam

This figure shows the co-authorship network connecting the top 25 collaborators of N Sivalingam. A scholar is included among the top collaborators of N Sivalingam based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with N Sivalingam. N Sivalingam is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Sritharan, Sruthi & N Sivalingam. (2025). A recent decade update on combating doxorubicin-induced toxicities. Archives of Toxicology. 99(9). 3565–3578. 1 indexed citations
2.
Sritharan, Sruthi & N Sivalingam. (2024). Secretion of IL-6 and TGF-β2 by Colon Cancer Cells May Promote Resistance to Chemotherapy. Indian Journal of Clinical Biochemistry. 41(2). 259–266. 1 indexed citations
3.
Sivalingam, N, et al.. (2024). Mechanism of 5-fluorouracil induced resistance and role of piperine and curcumin as chemo-sensitizers in colon cancer. Naunyn-Schmiedeberg s Archives of Pharmacology. 397(11). 8445–8475. 8 indexed citations
4.
Sritharan, Sruthi & N Sivalingam. (2024). Doxorubicin-induced chemoresistance in Duke’s type B colon adenocarcinoma cell line is aggravated in the presence of TGF-β2 through non-apoptotic cell death. Clinical & Translational Oncology. 26(7). 1630–1638. 1 indexed citations
5.
Sritharan, Sruthi, et al.. (2022). Meta analysis of bioactive compounds, miRNA, siRNA and cell death regulators as sensitizers to doxorubicin induced chemoresistance. APOPTOSIS. 27(9-10). 622–646. 9 indexed citations
6.
Sivalingam, N, et al.. (2021). Vanillin extracted from proso and barnyard millets induces cell cycle inhibition and apoptotic cell death in MCF-7 cell line. Journal of Cancer Research and Therapeutics. 17(6). 1425–1433. 19 indexed citations
7.
Sivalingam, N, et al.. (2020). Cichorium intybus attenuates Streptozotocin-induced pancreatic β-cell damage by inhibiting NF-κB activation and oxidative stress. Journal of Applied Biomedicine. 18(2-3). 70–79. 4 indexed citations
8.
Sritharan, Sruthi, et al.. (2020). Curcumin induces chemosensitization to doxorubicin in Duke’s type B coloadenocarcinoma cell line. Molecular Biology Reports. 47(10). 7883–7892. 13 indexed citations
10.
Jiang, Yong, Alec N. Woosley, N Sivalingam, Sneha Natarajan, & Philip H. Howe. (2016). Cathepsin-B-mediated cleavage of Disabled-2 regulates TGF-β-induced autophagy. Nature Cell Biology. 18(8). 851–863. 50 indexed citations
11.
Ramamoorthi, Ganesan & N Sivalingam. (2014). Molecular mechanism of TGF-β signaling pathway in colon carcinogenesis and status of curcumin as chemopreventive strategy. Tumor Biology. 35(8). 7295–7305. 34 indexed citations
12.
Sivalingam, N, et al.. (2010). Zinc protects against indomethacin-induced damage in the rat small intestine. European Journal of Pharmacology. 654(1). 106–116. 18 indexed citations
13.
Sivalingam, N, Jayasree Basivireddy, Anna Pulimood, K.A. Balasubramanian, & Molly Jacob. (2009). Activation of phospholipase A2 is involved in indomethacin-induced damage in Caco-2 cells. Toxicology in Vitro. 23(5). 887–896. 11 indexed citations
14.
Sivalingam, N, et al.. (2007). Curcumin reduces indomethacin‐induced damage in the rat small intestine. Journal of Applied Toxicology. 27(6). 551–560. 32 indexed citations
15.
Sivalingam, N, et al.. (2007). Medical students in their final six months of training: progress in self-perceived clinical competence, and relationship between experience and confidence in practical skills.. PubMed. 48(11). 1018–27. 21 indexed citations
16.
Sivalingam, N, Jayasree Basivireddy, Kunissery A. Balasubramanian, & Molly Jacob. (2007). Curcumin attenuates indomethacin-induced oxidative stress and mitochondrial dysfunction. Archives of Toxicology. 82(7). 471–481. 45 indexed citations
17.
Sivalingam, N. (2004). Teaching and Learning of Professionalism in Medical Schools. Annals of the Academy of Medicine Singapore. 33(6). 706–710. 16 indexed citations
18.
Sivalingam, N, et al.. (2004). Gestational trophoblastic disease.. PubMed. 59(5). 697–702; quiz 703. 5 indexed citations
19.
Sivalingam, N, et al.. (2000). Delayed diagnosis of cervical pregnancy: management options.. PubMed. 41(12). 599–601. 9 indexed citations
20.
Sivalingam, N, et al.. (1989). Internal Iliac and Ovarian Artery Ligation in the Control of Pelvic Haemorrhage. Australian and New Zealand Journal of Obstetrics and Gynaecology. 29(1). 22–25. 33 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026